Шановні коритсувачі репозитарію! В період з 31.12.2025 по 12.01.2026 на сервері репозитарію будуть виконуватися технічні роботи. Не намагайтеся в цей період розміщувати або редагувати свої роботи. Дякуємо за розуміння. Dear repository users! From 12/31/2025 to 01/12/2026, technical work will be performed on the repository server. Please do not attempt to post or edit your work during this period. Thank you for your understanding.
 

Oncostatin M activity and cardiac remodeling in patients with arterial hypertension and type 2 diabetes mellitus.

Loading...
Thumbnail Image

Date

Editor(s)

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Oncostatin M (OSM) is an inflammatory cytokine that belongs to the interleukin-6 (IL-6) class of cytokines. Members of this family mostly associated with cardiac hypertrophy due to activation of the common coreceptor gp130. Influence of OSM on cardiomyocytes in human is still controversial. Functional studies revealed that OSM is sufficient to induce dedifferentiation of cardiomyocytes in vitro and in vivo. OSM induces heterodimerization of gp130 with the OSM receptor β. Left ventricle (LV) remodeling is known as predictor of macrovascular outcomes in patients with arterial hypertension (AH) and type 2 diabetes mellitus (T2DM).

Description

Citation

Demydenko G. Oncostatin M activity and cardiac remodeling in patients with arterial hypertension and type 2 diabetes mellitus / G. Demydenko, O. Kovalyova, O. Kochubei // Journal of Hypertension. – 2012. – Vol. 30, Supl. A, April. – P. 448–449.

Endorsement

Review

Supplemented By

Referenced By